| Chris Adams | ||||||||||||
|
CEO |
||||||||||||
|
||||||||||||
| Download information as a vCard | ||||||||||||
|
|
||||||||||||
Latest News
- Compellis Pharmaceuticals Presents Results of Pilot Clinical Study at Obesity Society Annual Meeting
- Pennington Biomedical Research Institute and Compellis Pharmaceuticals Complete Phase I Study of Novel and Patented Obesity Therapy
- Compellis Pharmaceuticals, Inc. Awarded Second Broad Patent from the U.S. Patent Office for Novel Obesity Therapy
- Pennington Biomedical Research Institute Receives FDA Approval to Begin Phase I Studies of Compellis Pharmaceuticals’ Novel and Patented Obesity Therapy
- Compellis Pharmaceuticals Awarded Patent for its Therapeutic Platform for Treating Obesity